Viewing Study NCT00303927


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-01-25 @ 6:01 AM
Study NCT ID: NCT00303927
Status: COMPLETED
Last Update Posted: 2010-03-19
First Post: 2006-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent pancreatic cancer View
None stage IV pancreatic cancer View